1,000+ Opportunities

Find the right grant

Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.

ActiveNew York State Department of Health AIDS Institute · 2026

Expansion of NYS Drug User Health Hubs and Syringe Service Programs

Quick Facts

Agency: New York State Department of Health AIDS Institute
Funding: $12,590,000 over two years
Deadline: Check Source
Status: Active
Eligibility: Community-based organizations designated as Syringe Exchange Programs in New York State, authorized by the New York State Department of Health Commissioner.

About This Grant

Expansion of NYS Drug User Health Hubs and Syringe Service Programs is sponsored by New York State Department of Health AIDS Institute. This initiative expands Drug User Health Hubs and Syringe Service Programs to provide additional drug user health services, including mental health, medications for opioid use disorder, and reproductive health care education/counseling.

View Original RFP

Get alerted about grants like this

Save a search for “New York State Department of Health AIDS Institute” or related topics and get emailed when new opportunities appear.

Search similar grants →

Official Opportunity Details

Extracted from the official opportunity page/RFP to help you evaluate fit faster.

Expanded syringe access demonstration program in New York State: An intervention to prevent HIV/AIDS transmission - PMC As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. .

2000 Dec;77(4):762–767. doi: 10.

1007/BF02344036 Expanded syringe access demonstration program in New York State: An intervention to prevent HIV/AIDS transmission 1 Division of HIV Prevention, AIDS Institute, New York State Department of Health, Corning Tower, Room 308, 12237-0684 Albany, NY Find articles by Susan J Klein 1, ✉ , Guthrie S Birkhead Guthrie S Birkhead , MD, MPH 2 AIDS Institute, AIDS Institute, New York State Department of Health, Corning Tower, Room 308, 12237-0684 Albany, NY Find articles by Guthrie S Birkhead 3 Bureau of Special Populations, Division of HIV Prevention, AIDS Institute, New York State Department of Health, Corning Tower, Room 308, 12237-0684 Albany, NY Find articles by Alma R Candelas 1 Division of HIV Prevention, AIDS Institute, New York State Department of Health, Corning Tower, Room 308, 12237-0684 Albany, NY 2 AIDS Institute, AIDS Institute, New York State Department of Health, Corning Tower, Room 308, 12237-0684 Albany, NY 3 Bureau of Special Populations, Division of HIV Prevention, AIDS Institute, New York State Department of Health, Corning Tower, Room 308, 12237-0684 Albany, NY PMCID: PMC3456758 PMID: 11194315 The Full Text of this article is available as a PDF (306.

4 KB). 1. Holmberg SD.

The estimated prevalence and incidence of HIV in 96 larger US metropolitan areas. Am J Public Health. 1996;86:642–654.

doi: 10. 2105/ajph. 86.

5. 642. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 2.

Jarlais DC, Perlis T, Friedman SR, et al. Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996. Am J Public Health.

1998;12:1801–1806. doi: 10. 2105/ajph.

88. 12. 1801.

[ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 3. AIDS Cases by Year of Diagnosis, Includes Inmates, Data as of December 31, 1999. Albany, NY: New York State Department of Health, Bureau of HIV/AIDS Epidemiology; 1999.

[ Google Scholar ] 4. Smith PF, Mikl J, Hyde S, Morse DL. The AIDS epidemic in New York State.

Am J Public Health. 1991;81:54–60. doi: 10.

2105/ajph. 81. suppl.

54. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 5. AIDS Surveillance Quarterly Update for Cases Reported Through March 2000.

Albany, NY: New York State Department of Health, Bureau of HIV/AIDS Epidemiology; 2000. [ Google Scholar ] 6. Report on Needle Exchange Programs and Deregulation of Needles and Syringes.

Albany, NY: The New York State AIDS Advisory Council; 1996. [ Google Scholar ] 7. State of New York Official Compilation of Codes, Rules and Regulations .

10 NYCRR, Section 80. 135. Albany, NY: Lenz and Riecker.

8. State of New York. Public Health Law .

Book 44, Article 13, Title 13, Section 1389-dd(4). St. Paul, MN: West Publishing.

9. Wasserman S. HIV/AIDS Facts to Consider: 1999.

Denver, CO: National Conference of State Legislatures; 1999. pp. 65–65.

[ Google Scholar ] 10. State of New York. Public Health Law .

Book 44 , Article 33, Title 7, Section 3381. St. Paul, MN: West Publishing.

11. English T. New York is the latest state to permit over-the-counter sales of syringes and needles in pharmacies.

Pharm Today. 2000;6:20–20. [ Google Scholar ] 12.

Groseclose SL, Weinstein B, Jones TS, Valleroy LA, Fehrs LJ, Kassler WJ. Impact of increased legal access to needles and syringes on the practices of injecting drug users and police officers—Connecticut, 1992–1993. J Acquir Immune Defic Syndr Hum Retrovirol.

1995;10:82–89. [ PubMed ] [ Google Scholar ] 13. Valleroy LA, Weinstein B, Jones TS, Groseclose SL, Rolfs RT, Kassler WJ.

Impact of increased legal access to needles and syringes on community pharmacies needle and syringe sales—Connecticut, 1992–1993. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10(1):73–81.

[ PubMed ] [ Google Scholar ] 14. Beckett GA, Galena R, Shields D, Mills DA. Maine removed criminal penalties for syringe possession in 1997 after allowing sale of syringes without a prescription in 1993.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(suppl 1):S145–S146. doi: 10.

1097/00042560-199802001-00028. [ DOI ] [ PubMed ] [ Google Scholar ] 15. Minnesota Pharmacy Syringe/Needle Access Initiative.

Minneapolis, MN: Minnesota Department of Health; 1998. [ Google Scholar ] 16. Linas BP, Coffin PO, Backes G, Vlahov D.

New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation. J Urban Health. 2000;77(4):768–780.

doi: 10. 1007/BF02344037. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] 17.

Coffin PO, Linas BP, Factor SH, Vlahov D. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access. J Urban Health.

2000;77(4):781–793. doi: 10. 1007/BF02344038.

[ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ] Add to an existing collection Unable to load your collection due to an error

Eligibility Requirements

Community-based organizations designated as Syringe Exchange Programs in New York State, authorized by the New York State Department of Health Commissioner.

Frequently Asked Questions

Who can apply for Expansion of NYS Drug User Health Hubs and Syringe Service Programs?

According to the current listing, eligibility includes: Community-based organizations designated as Syringe Exchange Programs in New York State, authorized by the New York State Department of Health Commissioner. Confirm the full requirements in the official notice before applying.

How much funding does Expansion of NYS Drug User Health Hubs and Syringe Service Programs offer?

The current listing shows $12,590,000 over two years. Verify award ceilings, matching requirements, and allowable costs in the official notice.

Who funds Expansion of NYS Drug User Health Hubs and Syringe Service Programs?

Expansion of NYS Drug User Health Hubs and Syringe Service Programs is funded by New York State Department of Health AIDS Institute. Verify program details on the funder's official page before applying.

Which states are eligible for Expansion of NYS Drug User Health Hubs and Syringe Service Programs?

This opportunity targets applicants in New York. If your organization operates elsewhere, check the official notice for location requirements.

How do I apply for Expansion of NYS Drug User Health Hubs and Syringe Service Programs?

Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.

Browse grants by state

Grants in New York

Funder Profile

Ready to start your proposal?

Granted drafts, reviews, and strengthens your grant application — saving weeks of work. Professional members win a grant in 12 months or get a full refund.

Browse More Grants

Backed by the Granted Guarantee

Similar Grants from Other Funders

National Cancer Institute (NCI)

VerifiedDeadline Passed

NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32 - Independent Clinical Trial Not Allowed)

NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.

VariesDeadline: Jun 12, 2025 (passed)

New York State Department of Health AIDS Institute Grant Writing Tips

The Lilly Foundation's 2026 Open Call Is Really Three Different Grants Wearing One Application — And Where You're Located Decides Which One You Can Win

The Eli Lilly and Company Foundation's 2026 Open Call opened June 1 and closes July 3, across three focus areas: Global Health, K-12 STEM Education, and Economic Mobility. But two of the three only fund Marion County, Indiana. Here is how to read the geographic fine print, why the funder's commercial identity shapes what wins, and how to position a proposal that actually fits.

Read article

The Lilly Foundation's 2026 Open Call Closes July 3. Two of Its Three Priorities Are Quietly Geofenced to One Indiana County — and Most Applicants Won't Read the Map Until It's Too Late.

The Lilly Foundation's 2026 Open Call accepts pre-applications June 1 through July 3. Its three priorities — Global Health, K-12 STEM Education, and Economic Mobility — look national, but the education and mobility tracks concentrate heavily in Marion County, Indiana, while the health track funds cardiometabolic work abroad. Here's how to read the geography before you spend a week on a pre-application you can't win.

Read article

CDC's $75 Million Global Health Security NOFO Closes June 25 — and the Eight Cooperative Agreements Will Define the Post-USAID Outbreak Architecture

The CDC's Notice of Funding Opportunity CDC-RFA-JG-26-0056, Continuing to Enhance Global Health Security, closes for applications on June 25, 2026, with $75 million on the table and eight cooperative agreements anticipated. The NOFO sits inside an unusually compressed window for global health implementing partners — after the USAID dismantling and the 2025 CDC reorganization, this is one of the largest remaining flexible federal vehicles for outbreak-prevention work executed through bilateral partnerships with foreign health ministries. Here is what the solicitation requires, why the eligibility design favors specific applicant types, and what to do if you are still considering whether to apply.

Read article